Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Amoxicillin Clavulanate Potassium Powder for Suspension has been deemed to have passed the generic drug quality and efficacy consistency evaluation.

23/01/2025

GMT Eight

Guangzhou Baiyunshan Pharmaceutical Holdings (00874) announced that its subsidiary, Guangzhou Baiyunshan Pharmaceutical Holdings Medicine Group Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory ("Guangzhou Baiyunshan Pharmaceutical Holdings Pharmaceutical Factory"), has received a "Notice of Supplementary Application Approval" issued by the National Medical Products Administration. Amoxicillin clavulanate potassium dry powder for suspension has been deemed to pass the generic drug quality and efficacy consistency evaluation.

Hangzhou MDK Opto Electronics Co., Ltd (688079.SH) forecasts a pre-loss, with an estimated net loss of approximately 98,927,000 yuan in 2024.

Guangdong Jinma Entertainment Corporation (300756.SZ) issued a profit warning, with an estimated annual net profit of 7.6 million to 11.4 million yuan, a year-on-year decrease of 75.31% to 83.54%

Contact: contact@gmteight.com

Guangzhou Baiyunshan Pharmaceutical Holdings (00874): Amoxicillin Clavulanate Potassium Powder for Suspension has been deemed to have passed the generic drug quality and efficacy consistency evaluation.

RECOMMEND

HK Stock Market Move | Chip stocks rally across the board Semiconductor companies intensively disclose performance pre-earnings beats. Institutions claim that localization remains the core growth logic.

HK Stock Market Move |

HK Stock Market Move | TRIP.COM-S (09961) rose more than 4% with high certainty of increased consumption for the Spring Festival travel. Inbound tourism business may serve as a strong catalyst for the company.